Tocqueville Asset Management L.P. Omeros Corp Transaction History

Tocqueville Asset Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 14, 2020	SELL	$13.01 - $17.15 $147,013 - $193,794	-11,300 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$15.0 - $19.62 $204,000 - $266,832	-13,600 Reduced 54.62%	11,300 $177,000
Q1 2019 Apr 30, 2019	BUY	$11.65 - $17.72 $5,825 - $8,860	500 Added 2.05%	24,900 $433,000
Q4 2018 Feb 08, 2019	BUY	$10.72 - $16.73 $7,504 - $11,711	700 Added 2.95%	24,400 $272,000
Q3 2018 Nov 13, 2018	BUY	$17.73 - $26.69 $83,331 - $125,443	4,700 Added 24.74%	23,700 $579,000
Q2 2018 Aug 13, 2018	SELL	$10.79 - $24.44 $690,657 - $1.56 Million	-64,009 Reduced 77.11%	19,000 $345,000
Q1 2018 May 14, 2018	SELL	$9.0 - $20.16 $1.86 Million - $4.18 Million	-207,110 Reduced 71.39%	83,009 $927,000
Q4 2017 Feb 13, 2018	SELL	$13.26 - $22.86 $2.53 Million - $4.36 Million	-190,777 Reduced 39.67%	290,119 $5.64 Million
Q3 2017 Oct 30, 2017	BUY	$19.76 - $24.9 $9.5 Million - $12 Million	480,896	480,896 $10.4 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $712M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.